Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma

Venetoclax monotherapy is effective in 40% of t(11:14) positive multiple myeloma (MM). Here, the authors show that electron transport chain complex I (CI) and complex II (CII) activity predict MM sensitivity to venetoclax, and inhibition of CI with IACS-010759 or CII with TTFA increase sensitivity.

Bibliographic Details
Main Authors: Richa Bajpai, Aditi Sharma, Abhinav Achreja, Claudia L. Edgar, Changyong Wei, Arusha A. Siddiqa, Vikas A. Gupta, Shannon M. Matulis, Samuel K. McBrayer, Anjali Mittal, Manali Rupji, Benjamin G. Barwick, Sagar Lonial, Ajay K. Nooka, Lawrence H. Boise, Deepak Nagrath, Mala Shanmugam
Format: Article
Language:English
Published: Nature Portfolio 2020-03-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-020-15051-z
_version_ 1818422688090161152
author Richa Bajpai
Aditi Sharma
Abhinav Achreja
Claudia L. Edgar
Changyong Wei
Arusha A. Siddiqa
Vikas A. Gupta
Shannon M. Matulis
Samuel K. McBrayer
Anjali Mittal
Manali Rupji
Benjamin G. Barwick
Sagar Lonial
Ajay K. Nooka
Lawrence H. Boise
Deepak Nagrath
Mala Shanmugam
author_facet Richa Bajpai
Aditi Sharma
Abhinav Achreja
Claudia L. Edgar
Changyong Wei
Arusha A. Siddiqa
Vikas A. Gupta
Shannon M. Matulis
Samuel K. McBrayer
Anjali Mittal
Manali Rupji
Benjamin G. Barwick
Sagar Lonial
Ajay K. Nooka
Lawrence H. Boise
Deepak Nagrath
Mala Shanmugam
author_sort Richa Bajpai
collection DOAJ
description Venetoclax monotherapy is effective in 40% of t(11:14) positive multiple myeloma (MM). Here, the authors show that electron transport chain complex I (CI) and complex II (CII) activity predict MM sensitivity to venetoclax, and inhibition of CI with IACS-010759 or CII with TTFA increase sensitivity.
first_indexed 2024-12-14T13:30:13Z
format Article
id doaj.art-ab542c51a366402d8b83cd98c687f243
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-12-14T13:30:13Z
publishDate 2020-03-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-ab542c51a366402d8b83cd98c687f2432022-12-21T22:59:44ZengNature PortfolioNature Communications2041-17232020-03-0111111610.1038/s41467-020-15051-zElectron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myelomaRicha Bajpai0Aditi Sharma1Abhinav Achreja2Claudia L. Edgar3Changyong Wei4Arusha A. Siddiqa5Vikas A. Gupta6Shannon M. Matulis7Samuel K. McBrayer8Anjali Mittal9Manali Rupji10Benjamin G. Barwick11Sagar Lonial12Ajay K. Nooka13Lawrence H. Boise14Deepak Nagrath15Mala Shanmugam16Department of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory UniversityDepartment of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory UniversityDepartment of Biomedical Engineering, University of MichiganDepartment of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory UniversityDepartment of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory UniversityDepartment of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory UniversityDepartment of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory UniversityDepartment of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory UniversityChildren’s Medical Center Research Institute, University of Texas Southwestern Medical CenterBiointerfaces Institute, University of MichiganDepartment of Biostatistics and Bioinformatics Shared Resource, Winship Cancer Institute, Emory UniversityDepartment of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory UniversityDepartment of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory UniversityDepartment of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory UniversityDepartment of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory UniversityDepartment of Biomedical Engineering, University of MichiganDepartment of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory UniversityVenetoclax monotherapy is effective in 40% of t(11:14) positive multiple myeloma (MM). Here, the authors show that electron transport chain complex I (CI) and complex II (CII) activity predict MM sensitivity to venetoclax, and inhibition of CI with IACS-010759 or CII with TTFA increase sensitivity.https://doi.org/10.1038/s41467-020-15051-z
spellingShingle Richa Bajpai
Aditi Sharma
Abhinav Achreja
Claudia L. Edgar
Changyong Wei
Arusha A. Siddiqa
Vikas A. Gupta
Shannon M. Matulis
Samuel K. McBrayer
Anjali Mittal
Manali Rupji
Benjamin G. Barwick
Sagar Lonial
Ajay K. Nooka
Lawrence H. Boise
Deepak Nagrath
Mala Shanmugam
Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma
Nature Communications
title Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma
title_full Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma
title_fullStr Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma
title_full_unstemmed Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma
title_short Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma
title_sort electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma
url https://doi.org/10.1038/s41467-020-15051-z
work_keys_str_mv AT richabajpai electrontransportchainactivityisapredictorandtargetforvenetoclaxsensitivityinmultiplemyeloma
AT aditisharma electrontransportchainactivityisapredictorandtargetforvenetoclaxsensitivityinmultiplemyeloma
AT abhinavachreja electrontransportchainactivityisapredictorandtargetforvenetoclaxsensitivityinmultiplemyeloma
AT claudialedgar electrontransportchainactivityisapredictorandtargetforvenetoclaxsensitivityinmultiplemyeloma
AT changyongwei electrontransportchainactivityisapredictorandtargetforvenetoclaxsensitivityinmultiplemyeloma
AT arushaasiddiqa electrontransportchainactivityisapredictorandtargetforvenetoclaxsensitivityinmultiplemyeloma
AT vikasagupta electrontransportchainactivityisapredictorandtargetforvenetoclaxsensitivityinmultiplemyeloma
AT shannonmmatulis electrontransportchainactivityisapredictorandtargetforvenetoclaxsensitivityinmultiplemyeloma
AT samuelkmcbrayer electrontransportchainactivityisapredictorandtargetforvenetoclaxsensitivityinmultiplemyeloma
AT anjalimittal electrontransportchainactivityisapredictorandtargetforvenetoclaxsensitivityinmultiplemyeloma
AT manalirupji electrontransportchainactivityisapredictorandtargetforvenetoclaxsensitivityinmultiplemyeloma
AT benjamingbarwick electrontransportchainactivityisapredictorandtargetforvenetoclaxsensitivityinmultiplemyeloma
AT sagarlonial electrontransportchainactivityisapredictorandtargetforvenetoclaxsensitivityinmultiplemyeloma
AT ajayknooka electrontransportchainactivityisapredictorandtargetforvenetoclaxsensitivityinmultiplemyeloma
AT lawrencehboise electrontransportchainactivityisapredictorandtargetforvenetoclaxsensitivityinmultiplemyeloma
AT deepaknagrath electrontransportchainactivityisapredictorandtargetforvenetoclaxsensitivityinmultiplemyeloma
AT malashanmugam electrontransportchainactivityisapredictorandtargetforvenetoclaxsensitivityinmultiplemyeloma